Topic

Aetna (CVS Health)

A collection of 1351 issues

How to Get Revcovi (elapegademase) Covered by Aetna CVS Health in Virginia: Complete PA Guide with Forms and Appeal Steps

Answer Box: Getting Revcovi Covered by Aetna CVS Health in Virginia Revcovi (elapegademase) requires prior authorization from Aetna CVS Health but is covered on the specialty tier for confirmed ADA-SCID cases. Submit a complete PA packet including genetic/enzyme testing, specialist documentation, and transplant failure evidence through the Aetna provider

Myths vs. Facts: Getting Oxbryta (voxelotor) Covered by Aetna (CVS Health) in Ohio After FDA Withdrawal

Answer Box: Oxbryta (voxelotor) Coverage Status Oxbryta (voxelotor) is no longer available in the United States. Pfizer voluntarily withdrew the medication globally on September 25-26, 2024, following FDA safety concerns about increased vaso-occlusive crises and deaths. Claims are now automatically denied due to loss of FDA approval. Fastest path to

How to Get Qinlock (Ripretinib) Covered by Aetna CVS Health in Pennsylvania: Complete Prior Authorization and Appeals Guide

Quick Answer: Qinlock (ripretinib) requires prior authorization from Aetna CVS Health in Pennsylvania. You'll need documented failure of three prior kinase inhibitors (imatinib, sunitinib, regorafenib), submit through the CVS Caremark portal or CoverMyMeds, and allow 15 business days for standard review. If denied, Pennsylvania's new external

How to Get Photrexa (Riboflavin) Covered by Aetna CVS Health in Texas: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Photrexa Covered by Aetna CVS Health in Texas Aetna CVS Health covers Photrexa (riboflavin ophthalmic solution) for corneal cross-linking in progressive keratoconus, but requires prior authorization with documented progression. Key requirements: serial corneal topography showing ≥1 diopter Kmax increase over 12 months, minimum corneal thickness ≥400 microns,

Renewing Elevidys (Delandistrogene Moxeparvovec-Rokl) Approval with Aetna CVS Health in California: What to Prepare & When

Answer Box: Elevidys Renewal Essentials Elevidys (delandistrogene moxeparvovec-rokl) is a one-time gene therapy, so traditional "renewal" doesn't apply. However, California DMD families may need ongoing coverage for monitoring labs, cardiac assessments, and potential complications. Start preparing 90 days before your plan year changes by documenting treatment

How to Get Oxlumo (Lumasiran) Covered by Aetna CVS Health in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Quick Path to Oxlumo Coverage To get Oxlumo (lumasiran) covered by Aetna CVS Health in New Jersey: Submit prior authorization with confirmed PH1 diagnosis (genetic AGXT testing or liver enzyme analysis), specialist prescription from nephrologist/geneticist, baseline eGFR ≥30 mL/min/1.73m², and urinary oxalate levels. Use

Do You Qualify for Ofev (nintedanib) Coverage by Aetna (CVS Health) in Washington? Decision Tree & Next Steps

Answer Box: Your Path to Ofev (nintedanib) Coverage If you have IPF, SSc-ILD, or progressive fibrosing ILD diagnosed by a pulmonologist with HRCT evidence, you likely qualify for Ofev coverage by Aetna (CVS Health). Required: pulmonologist prescription, HRCT showing fibrosis, recent PFTs (FVC ≥50% predicted, DLCO ≥30%), and baseline liver

Getting Blenrep (Belantamab Mafodotin) Covered by Aetna (CVS Health) in Washington: Complete Access Guide for Current and Future Approval

Answer Box: Current Blenrep Access Through Aetna in Washington Blenrep (belantamab mafodotin) is not commercially available through standard Aetna coverage due to its 2022 FDA withdrawal, with re-approval anticipated October 2025. Current access requires clinical trial enrollment or GSK expanded access programs. Washington residents denied coverage can appeal through Aetna&

How to Get Waylivra (Volanesorsen) Covered by Aetna CVS Health in California: Forms, Appeals, and Success Strategies

Answer Box: Getting Waylivra Covered by Aetna CVS Health in California Waylivra (volanesorsen) requires a medical exception request with Aetna CVS Health since it's not FDA-approved or on standard formularies. California patients must document confirmed familial chylomicronemia syndrome (FCS) via genetic testing, triglycerides >875 mg/dL, and

How to Get Blenrep (belantamab mafodotin) Covered by Aetna (CVS Health) in Pennsylvania: Appeals Guide with Forms and Timelines

Answer Box: Getting Blenrep Covered in Pennsylvania Blenrep (belantamab mafodotin) received FDA approval on October 23, 2025, for adults with relapsed or refractory multiple myeloma. Aetna (CVS Health) requires prior authorization through CVS Caremark for this specialty drug. If denied, Pennsylvania's external review program overturns approximately 50% of